Radium Capital
Website: http://radiumcapital.com.au
Member Contact: Tim Hynes
Position: State Manager – Victoria and Tasmania
Industry: Industry Support Services
Company Profile:
Radium Capital is Australia’s leading provider of R&D finance, proudly supporting the growth of the nation’s biotech, medtech and health innovation sectors.
Since 2017, we’ve deployed more than $925 million in non-dilutive funding to over 1,000 Australian innovators, helping life sciences companies launch, scale and commercialise faster.
We provide early access to the R&D Tax Incentive refund through Radium Advances — enabling eligible businesses to reinvest in growth, smooth cash flow, attract additional funding, and reduce capital outlay. Advances can be used as one-off injections or used strategically throughout the year and are designed to complement other forms of capital.
Radium Capital was created by entrepreneurs for entrepreneurs, with the goal of giving R&D-focused companies the right funding at the right time. We’re proud to play a role in strengthening Australia’s innovation ecosystem by providing capital, connections and trusted advice to help move ideas to impact.
We work with companies across the full spectrum of innovation, from startups to ASX-listed firms, and across sectors, including biotech, medtech, digital health and health innovation.
For expert advice on R&D finance for biotech and health innovators, contact BioMelbourne Network member Tim Hynes, Radium Capital’s State Manager – Victoria and Tasmania.
If you are eligible for the R&DTI refund, you can apply for a Radium Advance – read more about how we can help you achieve your goals, sooner.
